Atara Biotherapeutics Inc

Healthcare · Biotechnology

9.40$ -3.9% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Balance Sheet

Atara Biotherapeutics Inc (ATRA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 21 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ATRA
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	284	264	242	244	230	218	473	493	443	392	325	274	365	343	300	428	406	588	530	457	450	468	397	436	368	376	302	246	189	166	165	117	143	109	62	37	30	20	20	21
Current Assets	282	261	235	222	206	172	414	425	373	321	251	201	293	273	229	359	339	523	464	392	369	385	314	347	283	295	224	172	119	102	106	62	92	65	27	25	18	12	12	14
Cash	46	48	62	64	60	79	90	103	66	61	56	59	94	74	70	75	63	200	151	124	113	106	102	71	65	93	49	46	65	26	35	31	46	25	14	17	5.7	8.5	8.4	3.2
Cash & Short-Term Investments	278	256	231	217	200	166	407	417	365	310	238	190	283	259	215	348	327	501	435	373	357	371	302	331	265	243	205	154	102	52	46	35	67	42	14	22	14	8.5	8.4	9.9
Receivables	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.8	0.8	1.3	9.6	0.7	0.4	1.0	0.7	0.6	0.2	40	0.4	0.5	0.2	34	36	2.4	1.3	1.5	8.9	0.0	1.9	1.3	0.0	0.3
Inventory	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	0.0	–	–	0.0	1.6	5.3	7.9	6.6	9.7	16	19	14	11	0.0	0.0	0.0	0.0	–	–
Property, Plant & Equipment	2.1	3.3	4.4	20	22	44	58	66	68	69	58	57	56	54	54	54	52	51	51	63	53	80	9.1	82	78	6.3	5.9	5.3	64	–	–	–	–	–	–	–	–	–	–	–
Goodwill	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Liabilities	14	10	8.6	23	24	40	34	40	40	53	41	42	46	52	47	47	52	126	131	125	140	189	173	179	181	250	237	239	240	265	264	228	233	206	117	72	67	59	57	58
Current Liabilities	14	9.7	7.8	11	17	28	21	27	27	40	25	26	31	37	32	32	36	83	84	89	86	106	102	66	72	79	68	75	79	142	181	148	156	135	48	15	18	15	5.6	6.8
Short-Term Debt	–	–	–	–	–	0.5	10	10	–	0.6	0.6	–	–	1.6	–	–	–	2.0	23	28	29	2.8	–	31	0.8	14	25	13	13	12	14	14	15	14	14	2.2	12	11	1.0	1.1
Accounts Payable	4.5	2.8	2.2	5.2	5.5	15	6.1	6.5	6.2	3.7	6.2	6.4	5.2	8.0	8.1	5.1	5.2	7.1	17	12	17	17	12	13	11	6.9	5.1	4.1	6.5	3.7	2.9	5.3	2.1	4.4	1.4	1.8	0.3	0.1	0.6	0.8
Long-Term Debt	0.0	0.0	0.0	11	6.2	11	10	10	10	–	14	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Shareholders' Equity	270	254	233	221	206	178	439	452	403	339	284	232	318	291	253	381	354	462	399	332	310	280	224	257	187	127	65	7.5	-51	-99	-98	-111	-91	-97	-55	-35	-37	-39	-37	-37
Retained Earnings	-159	-177	-203	-230	-261	-297	-338	-389	-447	-527	-593	-668	-739	-818	-891	-969	-1,043	-1,125	-1,203	-1,287	-1,371	-1,465	-1,553	-1,534	-1,618	-1,693	-1,768	-1,839	-1,909	-1,969	-2,001	-2,020	-2,042	-2,055	-2,017	-2,014	-2,018	-2,022	-2,026	-2,031
Shares Outstanding	1.2	1.2	1.2	1.2	1.2	1.2	1.6	1.8	1.8	1.8	1.8	1.9	2.2	2.3	2.4	2.7	3.2	3.4	3.7	3.7	3.7	3.9	4.0	4.1	4.1	4.1	4.2	4.2	4.3	4.3	5.6	6.1	7.5	11	11	12	14	13	14	15

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings